ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c